| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 392 | 392 |
| Effect of exchange rate changes on cash and cash equivalents | 1 | -4 |
| Net (decrease) increase in cash and cash equivalents | -10,741 | -15,473 |
| Cash and cash equivalents at beginning of period | 161,439 | - |
| Cash and cash equivalents at end of period | 150,698 | - |
Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN)